🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate, in 2-10 year old subjects, the...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09-18
Trial ID
NCT00514904
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
The purpose of the study is to evaluate the persistence of the immune respo...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-03
Trial ID
NCT01266993
Treatments Being Tested
In this study, subjects who were vaccinated with a meningococcal polysaccha...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-19
Trial ID
NCT00661557
Treatments Being Tested
The purpose of the study is to investigate whether or not GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-09
Trial ID
NCT00674583
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-03
Trial ID
NCT01777308
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
In this study, the concentration of antibody to the vaccine one year, three...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-07
Trial ID
NCT00715910
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01767376
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-11
Trial ID
NCT01755689
Treatments Being Tested